Ravi Bhatia
University of Alabama at Birmingham(US)
Publications by Year
Research Areas
Chronic Myeloid Leukemia Treatments, Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Childhood Cancer Survivors' Quality of Life, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Predicting Chemotherapy Toxicity in Older Adults With Cancer: A Prospective Multicenter Study(2011)1,797 cited
- → Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome–positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance(2007)743 cited
- → High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group(2003)617 cited
- → PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia(2019)602 cited
- → miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts(2010)562 cited
- → Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment